- Home
- VTEX vs NPCE Comparison
VTEX vs NPCE Comparison
Compare VTEX & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTEX | NPCE |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.5M | 485.6M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VTEX | NPCE |
|---|---|---|
| Price | $3.87 | $13.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $5.97 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.2M | 200.2K |
| Earning Date | 05-05-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | $12.64 | $0.93 |
| Revenue Next Year | $10.57 | $25.47 |
| P/E Ratio | $43.33 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $2.84 | $7.56 |
| 52 Week High | $6.82 | $18.97 |
Technical Indicators
Market Signals| Indicator | VTEX | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 38.39 |
| Support Level | $3.68 | $12.47 |
| Resistance Level | $4.23 | $13.81 |
| Average True Range (ATR) | 0.20 | 0.83 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 66.20 | 33.54 |
Price Performance
Historical ComparisonAbout VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.